**Core Concept:** CD34 is a cell surface antigen expressed on hematopoietic stem cells, myeloid progenitor cells, and some endothelial cells. It plays a crucial role in blood cell production and development.

**Why the Correct Answer is Right:** CD34 is primarily used as a marker for hematopoietic stem cells and bone marrow (BM) engraftment monitoring in hematopoietic stem cell transplantation (HSCT) patients. It helps to assess the engraftment of donor stem cells and predict graft-versus-host disease (GVHD) risk. Additionally, CD34 is also used in diagnosing certain types of leukemia and lymphoma, as it is often overexpressed in these malignancies.

**Why Each Wrong Option is Incorrect:**

A. CD34 is not primarily used for diagnosing leukemia or lymphoma; instead, it is used to assess engraftment and risk of GVHD in HSCT patients.
B. Although CD34 is expressed in some endothelial cells, it is primarily used for hematopoietic stem cells and BM engraftment monitoring in HSCT.
C. CD34 is not primarily used for diagnosing solid tumors or solid tumors.
D. While CD34 is expressed in some endothelial cells, it is primarily used for hematopoietic stem cells and BM engraftment monitoring in HSCT.

**Clinical Pearl:** In HSCT, monitoring CD34+ cell engraftment is crucial for successful transplantation outcomes, as it indicates the successful infusion of donor stem cells and predicts GVHD risk. A higher CD34+ cell count is associated with faster engraftment, reduced transplant-related mortality, and improved overall survival.

**Correct Answer:** C. CD34 is primarily used for diagnosing leukemia and lymphoma, as it is often overexpressed in these malignancies.